FDA Acknowledgment Letter to Ingram Planetarium

The FDA, through its Center for Devices and Radiological Health (CDRH), has issued an acknowledgment letter to Ingram Planetarium, dated March 26, 2026. This notice confirms that the FDA has received a submission from Ingram Planetarium. As the document is an acknowledgment letter and no content is available for review, it signifies the initial step in a regulatory process without providing substantive details or new obligations.

Compliance officers should note this acknowledgment as a routine administrative communication. No immediate actions are required based on this notice alone. Further regulatory developments concerning Ingram Planetarium's submission would be communicated through subsequent FDA actions or guidance. The lack of available content means no specific compliance deadlines or penalties can be identified at this stage.